ESMA_QA_1202
Status: ✅ Answer Published
Link to ESMA Q&A tool: https://www.esma.europa.eu/publications-data/questions-answers/1202
Regulatory Context
Regulation : UCITS
Level 1 Regulation: Undertakings for Collective Investment in Transferable Securities Directive (UCITS) Directive 2009/65/EC
Level 2 Regulation: No information available
Level 3 Regulation: No information available
Topic: UCITS global exposure
Subject Matter: Impact of EMIR on UCITS - Valuation of OTC derivatives
Question
Submission Date: 19 July 2016
For OTC financial derivative transactions that are centrally cleared and subject to the reporting obligation of EMIR, can UCITS management companies rely on the valuation provided by the central counterparty (CCP)?
ESMA Answer
Answer Date: 19-07-2016
[ESMA 34-43-392 UCITS Q&A, section 6, Q&A 1] No. The UCITS framework requires UCITS management companies to have in place a process for accurate and independent verification of the value of the OTC financial derivative transactions, even if they are centrally cleared. The valuation provided by the CCP can only serve as a point of reference for the verification performed by the UCITS management company. Nevertheless, the UCITS management company should be able to justify any deviation from the valuation provided by the CCP.
This document was automatically extracted from the ESMA EMIR Q&A database.